Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3Pituitary Neoplasms 3Prolactinoma 2Pituitary ACTH Hypersecretion 2Acromegaly 2Prostatic Neoplasms 1Ovarian Hyperstimulation Syndrome 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Heart Valve Diseases 1Dumping Syndrome 1Breast Neoplasms 1Brain Neoplasms 1ACTH-Secreting Pituitary Adenoma 1

Interventions

Cabergoline 2ropinirole 1pasireotide 1Lapatinib 1Clomiphene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Prolactinoma × Cabergoline × Clear all
NCT01620138 2016-08-22

Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas

Universidade Federal do Rio de Janeiro

Phase 2/3 Completed
21 enrolled 4 charts

Prolactinoma

NCT00460616 2008-04-16

ValveCab

Federico II University

Completed
50 enrolled

Heart Valve Diseases, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡